Projected number of people with diagnosed Type 2 diabetes in Germany in 2040

被引:88
|
作者
Toennies, T. [1 ]
Roeckl, S. [2 ]
Hoyer, A. [1 ]
Heidemann, C. [2 ]
Baumert, J. [2 ]
Du, Y. [2 ]
Scheidt-Nave, C. [2 ]
Brinks, R. [1 ,3 ]
机构
[1] Heinrich Heine Univ, Leibniz Ctr Diabet Res, German Diabet Ctr DDZ, Inst Biometr & Epidemiol, Dusseldorf, Germany
[2] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany
[3] Univ Hosp Duesseldorf, Hiller Res Unit Rheumatol, Dusseldorf, Germany
关键词
PREVALENCE; TRENDS; MORTALITY; MELLITUS; BURDEN; IMPACT; MODEL;
D O I
10.1111/dme.13902
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To project the number of people with Type 2 diabetes in Germany between 2015 and 2040. Methods Based on data from 65 million insurees of the German statutory health insurance, we projected the age-specific prevalence of diabetes using mathematical relations between prevalence, incidence rate and mortality. We compared several scenarios regarding temporal trends in the incidence and mortality rate. The projected age-specific prevalence was applied to the projected age structure of the German population between 2015 and 2040 to calculate the number of people with Type 2 diabetes. Results Application of current age-specific prevalence estimates to the projected age structure in 2040, although ignoring temporal trends in incidence and mortality, yielded an increase in the number of Type 2 diabetes cases from 6.9 million in 2015 to 8.3 million (+21%) in 2040. More realistic scenarios that account for decreasing mortality rates and different trends in the incidence rates project between 10.7 million (+54%) and 12.3 million (+77%) Type 2 diabetes cases in 2040. Conclusions For the first time, we projected the number of future Type 2 diabetes cases for the whole adult population in Germany. The results indicate a relative increase in the number of Type 2 diabetes cases of between 54% and 77% from 2015 to 2040. Temporal trends in the incidence rate are the main drivers of this increase. Simply applying current age-specific prevalence to the future age structure probably underestimates the future number of Type 2 diabetes cases.
引用
收藏
页码:1217 / 1225
页数:9
相关论文
共 50 条
  • [21] Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes
    Aleksander L. Hansen
    Reimar W. Thomsen
    Charlotte Brøns
    Helene M. L. Svane
    Rasmus T. Jensen
    Mette K. Andersen
    Torben Hansen
    Jens S. Nielsen
    Peter Vestergaard
    Kurt Højlund
    Niels Jessen
    Michael H. Olsen
    Henrik T. Sørensen
    Allan A. Vaag
    Diabetologia, 2023, 66 : 1680 - 1692
  • [22] Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes
    Hansen, Aleksander L.
    Thomsen, Reimar W.
    Brons, Charlotte
    Svane, Helene M. L.
    Jensen, Rasmus T.
    Andersen, Mette K.
    Hansen, Torben
    Nielsen, Jens S.
    Vestergaard, Peter
    Hojlund, Kurt
    Jessen, Niels
    Olsen, Michael H.
    Sorensen, Henrik T.
    Vaag, Allan A.
    DIABETOLOGIA, 2023, 66 (09) : 1680 - 1692
  • [23] Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes
    Parker, Victoria E. R.
    Robertson, Darren
    Erazo-Tapia, Edmundo
    Havekes, Bas
    Phielix, Esther
    de Ligt, Marlies
    Roumans, Kay H. M.
    Mevenkamp, Julian
    Sjoberg, Folke
    Schrauwen-Hinderling, Vera B.
    Johansson, Edvin
    Chang, Yi-Ting
    Esterline, Russell
    Smith, Kenneth
    Wilkinson, Daniel J.
    Hansen, Lars
    Johansson, Lars
    Ambery, Philip
    Jermutus, Lutz
    Schrauwen, Patrick
    NATURE METABOLISM, 2023, 5 (12) : 2148 - +
  • [24] Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes
    Victoria E. R. Parker
    Darren Robertson
    Edmundo Erazo-Tapia
    Bas Havekes
    Esther Phielix
    Marlies de Ligt
    Kay H. M. Roumans
    Julian Mevenkamp
    Folke Sjoberg
    Vera B. Schrauwen-Hinderling
    Edvin Johansson
    Yi-Ting Chang
    Russell Esterline
    Kenneth Smith
    Daniel J. Wilkinson
    Lars Hansen
    Lars Johansson
    Philip Ambery
    Lutz Jermutus
    Patrick Schrauwen
    Nature Metabolism, 2023, 5 : 2086 - 2093
  • [25] Sedentary time and markers of inflammation in people with newly diagnosed type 2 diabetes
    Falconer, C. L.
    Cooper, A. R.
    Walhin, J. P.
    Thompson, D.
    Page, A. S.
    Peters, T. J.
    Montgomery, A. A.
    Sharp, D. J.
    Dayan, C. M.
    Andrews, R. C.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (09) : 956 - 962
  • [26] An assessment of lifestyle video education for people newly diagnosed with type 2 diabetes
    Dyson, P. A.
    Beatty, S.
    Matthews, D. R.
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2010, 23 (04) : 353 - 359
  • [27] Mortality in people diagnosed with type 2 diabetes at an older age: a systematic review
    Barnett, Karen N.
    McMurdo, Marion E. T.
    Ogston, Simon A.
    Morris, Andrew D.
    Evans, Josie M. M.
    AGE AND AGEING, 2006, 35 (05) : 463 - 468
  • [28] The changing face of Type 2 diabetes in Scotland: characteristics of people with newly diagnosed Type 2 diabetes in 2004-2013
    Captieux, M. A.
    Kelt, I.
    DIABETIC MEDICINE, 2017, 34 : 22 - 23
  • [29] Socioeconomic inequalities in glycaemic control in people with newly diagnosed type 1 and type 2 diabetes
    Jacobs, E.
    Strassburger, K.
    Icks, A.
    Kuss, O.
    Burkhart, V.
    Szendroedi, J.
    Muessig, K.
    Rathmann, W.
    Roden, M.
    DIABETOLOGIA, 2018, 61 : S420 - S420
  • [30] Potential of prevention strategies for the modifiable risk factor type 2 diabetes with relation to the future number of dementia patients in Germany– a multi-state projection through 2040
    Anne Fink
    Achim Doerre
    Ilja Demuth
    Gabriele Doblhammer
    BMC Neurology, 22